SunRock Biopharma
Contact information
SunRock Biopharma S.L.
Juan Buela Fernández - Director
Edificio CSIEB, L1 Biopolo Sionlla, Rúa de Murcia, 3
Santiago de Compostela - 15017
+34 881 975 523
Areas of activities
- Oncology
Commissions
SunRock is a biopharmaceutical company, developing sophisticated therapeutic antibodies under innovative formats antibodies to treat incurable cancer. SunRock, working under an open innovation system, aims to develop the different programs from early discovery to the completion of phase I clinical trials.
Products and services
SunRock has developed an extensive portfolio of bispecific molecules targeting CCR9 and HER3 raising high expectation among the key players of the industry.
Biotech Sanitaria
| Product / Service | Type | Therapeutic area | Aplication | Development phase |
|---|---|---|---|---|
| SRB5 | Biodrugs/ Drugs | Enfermedades inflamatorias | Inflammatory Bowel Disease, Rheumatoid Arthritis | Preclinical |
| SRB123-ADC | Biodrugs/ Drugs | Oncología | Pancreatic, ovarian and lung tumors | Preclinical |